Inosine pranobex
Code | Size | Price |
---|
TAR-T3614-500mg | 500mg | £104.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T3614-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Isoprinosine has a number of immunomodulatory effects, including inducing T-lymphocyte differentiation, augmenting macrophage and NK cell functions, and stimulating IL-2 production. Through these effects and others, isoprinosine shows antiviral activity and has applications against subacute sclerosing panencephalitis. It also restores depressed immune responses in Y patients after irradiation and reduces the incidence of infection in leukemia patients undergoing chemotherapy. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
CAS:
36703-88-5
Formula:
C52H78N10O17
Molecular Weight:
1115.249
Pathway:
Proteases/Proteasome; Immunology/Inflammation; Microbiology/Virology
Purity:
0.9985
SMILES:
CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.CC(=O)Nc1ccc(cc1)C(O)=O.CC(=O)Nc1ccc(cc1)C(O)=O.CC(=O)Nc1ccc(cc1)C(O)=O.OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c1nc[nH]c2=O
Target:
IL Receptor; HIV Protease
References
Anna, et al. Cent Eur J Immunol. 2015; 40(4): 395?399.
Campoli-Richards DM, et al. November 1986, Volume 32, Issue 5: 383?424.
Beran J, et al. BMC Infect Dis. 2016; 16: 648.